MSD Pharmaceutical Pvt Ltd, India, part of Merck & Co Inc, USA, has launched Univadia, a unique online medical education portal for healthcare professionals in India. The interactive Univadis service will provide a wealth of medical resources, powerful tools, and accredited education courses from reputed and independent sources, exclusively for healthcare professionals MSD has strategically collaborated with the Lancet, one of the world's leading independent general medical journals, to bring exclusive content in the form of articles, news, research papers, medical advancements, videos and educational tools.
Univadis is an essential online resources for healthcare professionals that has been launched in more than 40 countries, is available in 17 languages with more than 20 million registered users worldwide. Univadis is free for health care professionals and contains no product advertising. Currently it appointed 12 physicians as advisers in India to go ahead with discussion with local bodies to meet local needs and contain. The information will be provided to registered healthcare professionals through www.univadis.in
K G Ananthakrishnan, managing director, MSD India, said, “We are proud to launch Univadis in India to aid comprehensive healthcare management, thereby making available unbiased, reliable scientific medical information across all parts of the country. Univadis portal provides high quality online education enabling healthcare practitioners to expand their knowledge and expertise and thereby offer better quality of care to their patients. MSD is known to be a trusted partner for continuous medical education across the globe and in India.”
Talking about the Lancet partnership with Univadis, Dr David Collingridge, publishing director for The Lancet's speciality journals, said, “Our partnership with Univadis offers a unique opportunity to increase delivery of the best science to Indian doctors in a free and easily accessible format, which will help promote best clinical practice and health systems reform.”